KRSNAA Share Price Performance
₹580.95
-150.80 (-20.61%)
14.8% undervalued intrinsic discount
₹682.00
Fair Value
Price ₹580.95
AnalystLowTarget ₹682.00
AnalystHighTarget ₹1,320.00
AnalystConsensusTarget ₹1,098.50
Fair Value₹682.00
Share Pricen/a
Krsnaa Diagnostics Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 33 Fair Values set on narratives written by author
KRSNAA Community Narratives
AN
Fair Value
·Fair Value ₹682 14.8% undervalued intrinsic discount
Government Delays And Cost Pressures Will Challenge Diagnostics Optimistically
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value ₹1.32k 56.0% undervalued intrinsic discount
India's Growing Healthcare Awareness Will Drive PPP And Retail Expansion
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value ₹1.1k 47.1% undervalued intrinsic discount
Rajasthan PPP And Retail Expansion Will Shape Healthcare Future
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
Government Delays And Cost Pressures Will Challenge Diagnostics Optimistically
Key Takeaways Heavy dependence on government partnerships makes Krsnaa vulnerable to policy changes, payment delays, and margin pressures despite recurring revenue streams. Intensifying competition, regulatory headwinds, and rapid expansion risks could limit profitability and returns, even as demand and digital adoption in diagnostics rise.Read more
AN
₹682
14.8% undervalued intrinsic discount
Fair Value
Revenue
19.79% p.a.
Profit Margin
12.21%
Future PE
19.31x
Price in 2029
₹960.61
Rajasthan PPP And Retail Expansion Will Shape Healthcare Future
Key Takeaways Geographic and retail expansion, supported by public-private partnerships and digital initiatives, is expected to drive revenue growth and improve margins. Increased healthcare demand and efficient collections are enhancing cash flow quality and strengthening long-term operational performance.Read more
AN
₹1.1k
47.1% undervalued intrinsic discount
Fair Value
Revenue
27.73% p.a.
Profit Margin
13.97%
Future PE
23.37x
Price in 2028
₹1.55k
India's Growing Healthcare Awareness Will Drive PPP And Retail Expansion
Key Takeaways Aggressive PPP and retail expansion, combined with tech-enabled cost advantages, position the company for structurally higher margins and outsized long-term earnings growth. First-mover status and deep hospital partnerships enable strong cross-selling, market share gains, and potential for continued industry-leading revenue and margin expansion.Read more
AN
₹1.32k
56.0% undervalued intrinsic discount
Fair Value
Revenue
26.02% p.a.
Profit Margin
14.08%
Future PE
29.02x
Price in 2028
₹1.87k
Trending Discussion
Recently Updated Narratives
AN
KRSNAA: Board And Interim CFO Changes Will Support Bullish Outlook
Fair Value: ₹682 14.8% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rajasthan PPP And Retail Expansion Will Shape Healthcare Future
Fair Value: ₹1.1k 47.1% undervalued intrinsic discount
13 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
India's Growing Healthcare Awareness Will Drive PPP And Retail Expansion
Fair Value: ₹1.32k 56.0% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Krsnaa Diagnostics Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
- 24.78
- 76.56%
- 10.49%
- 31.0%
About KRSNAA
- Founded
- 2010
- Employees
- 3471
- CEO
- WebsiteView website
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
Recent KRSNAA News & Updates
KRSNAA: Steady View Will Highlight CFO Exit As Key Catalyst
Analysts have kept the price target for Krsnaa Diagnostics steady at ₹682. They cite only slight adjustments in their assumptions for revenue growth, profit margin and future P/E as the main reasons for maintaining this view.
